Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/IB Safety and Pharmacodynamic Study of Neoadjuvant (NACT) Paclitaxel and Carboplatin With Ipatasertib as Initial Therapy of Ovarian Cancer PTMA 100805

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05276973
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:47.255458+00:00
Published At
2025-12-19T00:00:00+00:00
Record Updated At
2025-12-19
Results Posted At
2025-12-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube High Grade Serous Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian High Grade Serous Adenocarcinoma", "Primary Peritoneal Endometrioid Adenocarcinoma", "Primary Peritoneal High Grade Serous Adenocarcinoma", "Stage III Fallopian Tube Cancer AJCC v8", "Stage III Ovarian Cancer AJCC v8", "Stage III Primary Peritoneal Cancer AJCC v8", "Stage IV Fallopian Tube Cancer AJCC v8", "Stage IV Ovarian Cancer AJCC v8", "Stage IV Primary Peritoneal Cancer AJCC v8", "Unresectable Fallopian Tube Endometrioid Adenocarcinoma", "Unresectable Fallopian Tube High Grade Serous Adenocarcinoma", "Unresectable Ovarian Endometrioid Adenocarcinoma", "Unresectable Ovarian High Grade Serous Adenocarcinoma", "Unresectable Primary Peritoneal Endometrioid Adenocarcinoma", "Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-19"
protocolSection.identificationModule.nctId
"NCT05276973"
protocolSection.identificationModule.officialTitle
"Phase I/IB Safety and Pharmacodynamic Study of Neoadjuvant (NACT) Paclitaxel and Carboplatin With Ipatasertib as Initial Therapy of Ovarian Cancer PTMA 100805"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-12-19"

Study condition terms

  • Fallopian Tube Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Primary Peritoneal Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Primary Peritoneal High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Fallopian Tube Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Fallopian Tube High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Ovarian Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Ovarian High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Primary Peritoneal Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.